» Articles » PMID: 30816336

Efficacy and Safety of Enucleation Vs. Resection of Prostate for Treatment of Benign Prostatic Hyperplasia: a Meta-analysis of Randomized Controlled Trials

Overview
Specialties Oncology
Urology
Date 2019 Mar 1
PMID 30816336
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The purpose of this study is to compare the efficacy and safety of transurethral enucleation and resection of prostate for treatment of benign prostatic hyperplasia (BPH).

Materials And Methods: This meta-analysis was conducted through a systematic search before 1 September 2018. All included publications were randomized controlled trials (RCTs). Efficacy was evaluated based on International Prostate Symptom Score (IPSS), maximum urinary flow rate (Qmax), and quality of life (QoL). Perioperative data and complications postoperatively were also assessed. The quality assessment of included studies and results was performed by using the Cochrane System and GRADE (grading of recommendation assessment, development, and evaluation) System.

Results: Thirty-one publications involving 26 RCTs with 3283 patients were assessed in this review. The differences between enucleation and resection in IPSS, Qmax, and QoL at 1, 3, and 6 months postoperative were not significant. At 12 months postoperatively, IPSS and Qmax in the enucleation group were significantly better than those in the resection group. The results also suggested a benefit of enucleation over resection in hospital stay, hemoglobin loss, serum sodium decrease, blood transfusion rate, grade II, grade III complications, and early complications. However, resection exhibited a better operative time.

Conclusion: Compared with resection, enucleation showed better efficacy and safety postoperatively with less hematological changes and severe complications, except for longer operative time.

Citing Articles

Polygenic anti-cancer activity of in prostate cancer induced animal model.

Alabi G, Elekofehinti O, Sanni D, Ashaolu J, Oluwatuyi A Toxicol Rep. 2024; 13:101774.

PMID: 39554609 PMC: 11567122. DOI: 10.1016/j.toxrep.2024.101774.


Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature.

Lambertini L, Sandulli A, Coco S, Paganelli D, Cadenar A, Delloglio P Prostate Cancer Prostatic Dis. 2024; .

PMID: 39438691 DOI: 10.1038/s41391-024-00900-5.


Safety and efficacy of transurethral holmium laser enucleation of the prostate versus bipolar transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: a prospective randomized controlled trial.

Jiang B, Liang P, Wu Y, Wang W, Shen L Langenbecks Arch Surg. 2024; 409(1):313.

PMID: 39425787 DOI: 10.1007/s00423-024-03499-2.


Early Hemorrhagic Complications after Holmium Laser Enucleation of the Prostate in Patients Undergoing Antithrombotic Therapy: A Retrospective Analysis from a High-Volume Centre.

Pastore S, Carilli M, Di Nicola S, Campagna A, Parente U, Pierella F J Clin Med. 2024; 13(19).

PMID: 39408065 PMC: 11478196. DOI: 10.3390/jcm13196006.


Anatomic endoscopic enucleation of the prostate using a novel hybrid thulium:yttrium-aluminium-garnet laser generator: surgical technique and clinical outcomes.

Ventimiglia E, Orecchia L, Bevilacqua L, Tondelli E, Oliva I, Cindolo L World J Urol. 2024; 42(1):498.

PMID: 39214884 DOI: 10.1007/s00345-024-05207-7.


References
1.
Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P . Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10,654 patients. J Urol. 2008; 180(1):246-9. DOI: 10.1016/j.juro.2008.03.058. View

2.
Rassweiler J, Teber D, Kuntz R, Hofmann R . Complications of transurethral resection of the prostate (TURP)--incidence, management, and prevention. Eur Urol. 2006; 50(5):969-79. DOI: 10.1016/j.eururo.2005.12.042. View

3.
Ho H, Yip S, Lim K, Fook S, Foo K, Cheng C . A prospective randomized study comparing monopolar and bipolar transurethral resection of prostate using transurethral resection in saline (TURIS) system. Eur Urol. 2007; 52(2):517-22. DOI: 10.1016/j.eururo.2007.03.038. View

4.
Gilling P, Cass C, Malcolm A, Fraundorfer M . Combination holmium and Nd:YAG laser ablation of the prostate: initial clinical experience. J Endourol. 1995; 9(2):151-3. DOI: 10.1089/end.1995.9.151. View

5.
Herrmann T, Bach T, Imkamp F, Georgiou A, Burchardt M, Oelke M . Thulium laser enucleation of the prostate (ThuLEP): transurethral anatomical prostatectomy with laser support. Introduction of a novel technique for the treatment of benign prostatic obstruction. World J Urol. 2010; 28(1):45-51. DOI: 10.1007/s00345-009-0503-0. View